Matches in Wikidata for { <http://www.wikidata.org/entity/Q98604277> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q98604277 description "clinical trial" @default.
- Q98604277 description "ensayo clínico" @default.
- Q98604277 description "ensayu clínicu" @default.
- Q98604277 description "klinisch onderzoek" @default.
- Q98604277 description "клінічне випробування" @default.
- Q98604277 description "临床试验" @default.
- Q98604277 name "NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection" @default.
- Q98604277 name "NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection" @default.
- Q98604277 type Item @default.
- Q98604277 label "NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection" @default.
- Q98604277 label "NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection" @default.
- Q98604277 prefLabel "NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection" @default.
- Q98604277 prefLabel "NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection" @default.
- Q98604277 P1050 Q98604277-72F090E7-2B75-41C6-83FE-F00CB443F971 @default.
- Q98604277 P1132 Q98604277-46926BC8-5904-42BF-97CB-68C0A87CEAC6 @default.
- Q98604277 P1476 Q98604277-040BF7BE-7D9D-42CE-B798-CA0B1FE89D35 @default.
- Q98604277 P17 Q98604277-2B31C1E5-7448-4776-8A69-8148DACDCB5D @default.
- Q98604277 P1813 Q98604277-86638B23-FED5-4C10-B9C8-395C4DEBA433 @default.
- Q98604277 P2899 Q98604277-CE1C950B-32CF-4E8A-B61C-503933A74993 @default.
- Q98604277 P3098 Q98604277-DECDEDE0-9521-410B-9058-86F667D2FB0E @default.
- Q98604277 P31 Q98604277-476B4995-A008-4568-9088-7AA8DE39C036 @default.
- Q98604277 P4135 Q98604277-C324B672-BE8D-4697-9CB1-2998B5FA65D0 @default.
- Q98604277 P4844 Q98604277-50BFC14A-81C9-4B9D-A0F9-50FBF0208948 @default.
- Q98604277 P4844 Q98604277-8A5A8B67-B77F-4BFE-BAAC-159854879B3E @default.
- Q98604277 P4844 Q98604277-F66EBD56-937E-419E-B497-0AAA9A84D34A @default.
- Q98604277 P580 Q98604277-C13158AF-415B-4BCB-A809-B126D8B6E4D7 @default.
- Q98604277 P582 Q98604277-3FC8AEAD-EA6A-44AE-B7B7-B46EBD09C991 @default.
- Q98604277 P6099 Q98604277-5E8DA733-68C0-4A16-9C6C-0F921DB4BC79 @default.
- Q98604277 P6099 Q98604277-CA34EC46-8ABA-48D0-8074-32CB56D4A65E @default.
- Q98604277 P8005 Q98604277-0B69A46D-70D4-4920-B66C-D5B115600529 @default.
- Q98604277 P8363 Q98604277-2DB0661D-E90B-4912-918C-334469499494 @default.
- Q98604277 P1050 Q103177 @default.
- Q98604277 P1132 "+525" @default.
- Q98604277 P1476 "Randomized Controlled Phase 2/3 Clinical Trial of NA-831 Alone or With Atazanavir, or NA-831 With Dexamethasone, or Atazanavir With Dexamethasone in the Treatment of COVID-19 Infection" @default.
- Q98604277 P17 Q30 @default.
- Q98604277 P1813 "NATADEX" @default.
- Q98604277 P2899 "+18" @default.
- Q98604277 P3098 "NCT04452565" @default.
- Q98604277 P31 Q30612 @default.
- Q98604277 P4135 "+80" @default.
- Q98604277 P4844 Q15889608 @default.
- Q98604277 P4844 Q27114238 @default.
- Q98604277 P4844 Q408524 @default.
- Q98604277 P580 "2020-08-15T00:00:00Z" @default.
- Q98604277 P582 "2020-12-15T00:00:00Z" @default.
- Q98604277 P6099 Q42824440 @default.
- Q98604277 P6099 Q42824827 @default.
- Q98604277 P8005 Q76649708 @default.
- Q98604277 P8363 Q78089383 @default.